$18.27
3.26% today
Nasdaq, Nov 06, 09:19 pm CET
ISIN
US74340E1038
Symbol
PGNY

Progyny Inc Stock price

$18.88
-1.31 6.49% 1M
-4.52 19.32% 6M
+1.63 9.45% YTD
+3.09 19.57% 1Y
-21.48 53.22% 3Y
-8.47 30.97% 5Y
+2.94 18.44% 10Y
+2.94 18.44% 20Y
Nasdaq, Closing price Wed, Nov 05 2025
+0.31 1.67%

New AI Insights on Progyny Inc Insights AI Insights on Progyny Inc

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
$1.6b
Enterprise Value
$1.3b
Net debt
positive
Cash
$305.1m
Shares outstanding
85.9m
Valuation (TTM | estimate)
P/E
32.6 | 29.9
P/S
1.3 | 1.3
EV/Sales
1.1 | 1.0
EV/FCF
6.9
P/B
3.2
Financial Health
Equity Ratio
69.5%
Return on Equity
12.9%
ROCE
14.2%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$1.2b | $1.3b
EBITDA
$80.8m | $212.6m
EBIT
$76.8m | $208.3m
Net Income
$53.1m | $54.2m
Free Cash Flow
$190.2m
Growth (TTM | estimate)
Revenue
9.6% | 10.0%
EBITDA
9.4% | 201.1%
EBIT
7.8% | 208.8%
Net Income
-15.3% | -0.2%
Free Cash Flow
11.3%
Margin (TTM | estimate)
Gross
22.3%
EBITDA
6.5% | 16.6%
EBIT
6.2%
Net
4.3% | 4.2%
Free Cash Flow
15.3%
More
EPS
$0.6
FCF per Share
$2.2
Short interest
10.6%
Employees
678
Rev per Employee
$1.7m
Show more

Is Progyny Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.

Progyny Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Progyny Inc forecast:

10x Buy
63%
6x Hold
38%

Analyst Opinions

16 Analysts have issued a Progyny Inc forecast:

Buy
63%
Hold
38%

Financial data from Progyny Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1,242 1,242
10% 10%
100%
- Direct Costs 965 965
9% 9%
78%
277 277
11% 11%
22%
- Selling and Administrative Expenses 201 201
12% 12%
16%
- Research and Development Expense - -
-
-
81 81
9% 9%
7%
- Depreciation and Amortization 4.02 4.02
52% 52%
0%
EBIT (Operating Income) EBIT 77 77
8% 8%
6%
Net Profit 53 53
15% 15%
4%

In millions USD.

Don't miss a Thing! We will send you all news about Progyny Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Progyny Inc Stock News

Neutral
GlobeNewsWire
14 days ago
NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period ended September 30, 2025 after the close of the market on Thursday, November 6, 2025.
Neutral
GlobeNewsWire
15 days ago
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc . (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced the launch of its pregnancy, postpartum, and menopause programs for global employers, available starting January 1, 2026.
Neutral
GlobeNewsWire
about one month ago
Progyny joins global leaders to accelerate advancement in research, innovation, and resilience in women's health Progyny joins global leaders to accelerate advancement in research, innovation, and resilience in women's health
More Progyny Inc News

Company Profile

Progyny, Inc. is a medical device company. It engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. The firm operates through the following segments: medical device and fertility benefits solution. The company's services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.

Head office United States
CEO Peter Anevski
Employees 678
Founded 2008
Website www.progyny.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today